Throughout her career, Jelena has combined deep biological understanding with commercial clarity to identify structural limitations in traditional approaches and position practical solutions that advance fibrosis and epigenetics.
Jelena played a central role in building FibroFind into a commercially focused business, establishing its scientific foundations and translating early insight into a scalable platform. Under her leadership, the company progressed from concept to a globally recognised partner to the world’s leading pharmaceutical companies.
Check out the rest of the feature here
